| Identification | Back Directory | [Name]
Gosuranemab | [CAS]
1788032-39-2 | [Synonyms]
Gosuranemab
Research Grade Gosuranemab
Research Grade Gosuranemab (DHC82401) |
| Hazard Information | Back Directory | [Uses]
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemab?binds to human N-terminal?tau?residues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD)[1][2]. | [References]
[1] Song C, et al. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022 Mar 18;11(1):18. DOI:10.1186/s40035-022-00292-3
[2] Imbimbo BP, et al. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. Alzheimers Dement. 2022 May;18(5):1008-1037. DOI:10.1002/alz.12453 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|